Crospovidone

ExcipientUNII 2S7830E561

11 organisations hold 11 active FDA Type IV Drug Master Files for Crospovidone. 8 valid EDQM Certificates of Suitability are on record for the same substance.

Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity); EDQM Certification Online Database. Methodology

Active Type IV DMFs (11)

HolderDMFFiled asSubmitted
JIANGXI ALPHA HI-TECH PHARMACEUTICAL CO LTD42983CROSPOVIDONEDec 2025
ZHEJIANG RETRON BIOTECH CO LTD41056CROSPOVIDONEDec 2024
G.C. CHEMIE PHARMIE LTD40086CROSPOVIDONEJun 2024
SHANGHAI YUKING WATER SOLUBLE MATERIAL TECH CO LTD
China
38724CROSPOVIDONEAug 2023
ALCEDO PHARMACHEM PRIVATE LTD36620CROSPOVIDONE USP-NFDec 2021
BOAI NKY MEDICAL HOLDINGS LTD
China
35341CROSPOVIDONEDec 2020
ANHUI SUNHERE PHARMACEUTICAL EXCIPIENTS CO LTD34076CROSPOVIDONESept 2019
CNSG ANHUI HONG SIFANG CO LTD30700CROSPOVIDONEMay 2016
HUANGSHAN BONSUN PHARMACEUTICALS CO LTD29013CROSPOVIDONEJan 2015
STAR-TECH AND JRS SPECIALTY PRODUCTS CO LTD
China
28972CROSPOVIDONEDec 2014
JIAOZUO ZHONGWEI SPECIAL PRODUCTS PHARMACEUTICAL CO LTD28408CROSPOVIDONEJun 2014

“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.

Valid CEPs for this substance (8)

HolderCountryCertificateIssued
BOAI NKY MEDICAL HOLDINGS LTDCN
R0-CEP 2023-020 - Rev 00
Crospovidone, Type A and B
Aug 2023
CNSG ANHUI HONG SIFANG CO., LTD. Hefei City CNCN
R1-CEP 2016-264 - Rev 00
Crospovidone, Type B
Jan 2023
JH NANHANG LIFE SCIENCES CO., LTD. Quzhou CNCN
R1-CEP 2014-157 - Rev 00
Crospovidone, Type A and B
Feb 2021
HUANGSHAN BONSUN PHARMACEUTICALS CO., LTD. Shexian CNCN
R1-CEP 2014-344 - Rev 00
Crospovidone, Type A and B
Feb 2021
STAR-TECH AND JRS SPECIALTY PRODUCTS CO LTDCN
R1-CEP 2014-337 - Rev 00
Crospovidone, Type A and B
Nov 2020
JIAOZUO ZHONGWEI SPECIAL PRODUCTS PHARMACEUTICAL CO., LTD. Jiaozuo CNCN
R1-CEP 2012-195 - Rev 01
Crospovidone, Type A and B
Nov 2019
BASF SEDE
R1-CEP 2007-076 - Rev 01
Crospovidone, Type A and B
Jun 2015
International Specialty Products Wayne USUS
R1-CEP 2003-224 - Rev 00
Crospovidone
Feb 2011

Certification Online Database, European Directorate for the Quality of Medicines & HealthCare. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

What these records establish

  • A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
  • Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
  • The holder is the organisation that filed. It is usually, but not always, the manufacturer.
  • Many excipients are supplied without any DMF, so this list is not every supplier of Crospovidone.

How to qualify an excipient supplier

For suppliers

Do you supply Crospovidone?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.